WCBP 2007

Introduction

Welcome Message

Scientific Program

Workshops

Technical Seminars

Sponsorship

Co-Sponsorship

Exhibitors

Call for Papers

Submit Abstracts

Poster Instructions

Committee Members

Conference History

Hotel Information

Travel Center

Online Registration Center

Return User Logon

More Information

DOWNLOADS

CMC Strategy Forum  is being hosted in conjunction with the WCBP 2007.  CLICK HERE to visit the CMC Strategy Forum site.

 

October 13, 2006 Abstract deadline to be considered for oral presentation. December 13, 2006 Abstract deadline to be considered for poster presentation. Early Bird Registration Extended January 5, 2006 Early Bird Registration ends January 19, 2006 Online Registration Closes January 28-31, 2007 On Site Registration Monday, January 29, 2007 7:00 - 10:00 PM Welcome Reception Women's Memorial Museum SPONSORS & EXHIBITORS December 20, 2006 Deadline for Submitted Ad Copy

Symposium Co-Chairs
Philip Krause, CBER, FDA
John O’Connor, Genentech, Inc.
Patrick Swann, CDER, FDA

Meeting Announcement

This U.S. FDA jointly sponsored WCBP Symposium series is the pre-eminent conference addressing the analytical development/regulatory control interface for biotechnology derived health intervention products. The goal of this Symposium series is to provide a forum for discussing the latest bioanalytical methods and their practical application to biotechnology pharmaceuticals and other health related products. Both state-of-the-art innovations as well as conventional technologies addressing research and routine testing applications will be covered. This includes both method and instrumental advances which are used for product characterization, process development, in-process analysis and validated release & stability testing.

 

 

 

 

 

 

 

 

This U.S. FDA jointly sponsored WCBP Symposium series is the pre-eminent conference addressing the analytical development/regulatory control interface for biotechnology derived health intervention products. The goal of this Symposium series is to provide a forum for discussing the latest bioanalytical methods and their practical application to biotechnology pharmaceuticals and other health related products. Both state-of-the-art innovations as well as conventional technologies addressing research and routine testing applications will be covered. This includes both method and instrumental advances that are used for product characterization, process development, in-process analysis and validate release & stability testing.